Inhibition of RNA polymerase II as a trigger for the p53 response

[1]  B. McKay,et al.  Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis , 1998, Oncogene.

[2]  A. Levine,et al.  Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Brash,et al.  Antioxidant action via p53-mediated apoptosis. , 1998, Cancer research.

[4]  T. Hunter,et al.  Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells , 1998, Oncogene.

[5]  James M. Roberts,et al.  Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. , 1998, Molecular cell.

[6]  A. Takahashi,et al.  p53-dependent induction of WAF1 by cold shock in human glioblastoma cells , 1998, Oncogene.

[7]  W. P. McLaughlin,et al.  Butyrate attenuates BCLX(L) expression in human fibroblasts and acts in synergy with ionizing radiation to induce apoptosis. , 1998, Radiation research.

[8]  K. Yano,et al.  DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. , 1998, Genes & development.

[9]  M L Agarwal,et al.  The p53 Network* , 1998, The Journal of Biological Chemistry.

[10]  A. Giaccia,et al.  Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis , 1997, Molecular and cellular biology.

[11]  E. Appella,et al.  Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes , 1997, Molecular carcinogenesis.

[12]  B. Wasylyk,et al.  Transcription Abnormalities Potentiate Apoptosis of Normal Human Fibroblasts , 1997, Molecular medicine.

[13]  B. Gilchrest,et al.  Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Jongmans,et al.  Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation , 1997, Molecular and cellular biology.

[15]  Raouf Fetni,et al.  A p53-independent pathway for induction of p21waf1cip1 and concomitant G1 arrest in UV-irradiated human skin fibroblasts. , 1997, Cancer research.

[16]  L. Bracco,et al.  Proteolysis by calpains: a possible contribution to degradation of p53 , 1997, Molecular and cellular biology.

[17]  A. Ciechanover,et al.  On the involvement of calpains in the degradation of the tumor suppressor protein p53 , 1997, FEBS letters.

[18]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[19]  H. Drexler.  Activation of the cell death program by inhibition of proteasome function. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. McKay,et al.  Wildtype p53 is required for heat shock and ultraviolet light enhanced repair of a UV-damaged reporter gene. , 1997, Carcinogenesis.

[21]  J. Roth,et al.  Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol , 1997, Oncogene.

[22]  M. Kubbutat,et al.  Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability , 1997, Molecular and cellular biology.

[23]  P. Howley,et al.  Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation , 1997, Molecular and cellular biology.

[24]  A. Jochemsen,et al.  How phosphorylation regulates the activity of p53. , 1996, Journal of molecular biology.

[25]  P. O'Connor,et al.  Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation. , 1996, DNA and cell biology.

[26]  M. Vigneron,et al.  In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin. , 1996, Nucleic acids research.

[27]  M. Kastan.  Signalling to p53: where does it all start? , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[28]  M. Minden,et al.  Translational regulation of human p53 gene expression. , 1996, The EMBO journal.

[29]  K. Shinohara,et al.  Apoptosis induction resulting from proteasome inhibition. , 1996, The Biochemical journal.

[30]  M. Ljungman.  Effect of differential gene expression on the chromatin structure of the DHFR gene domain in vivo. , 1996, Biochimica et biophysica acta.

[31]  C. Harris,et al.  p53 tumor suppressor gene: from the basic research laboratory to the clinic--an abridged historical perspective. , 1996, Carcinogenesis.

[32]  P. Howley,et al.  In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.

[33]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[34]  G. Wahl,et al.  A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.

[35]  R. Tishler,et al.  Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. , 1995, Cancer research.

[36]  S. Lippard,et al.  DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo. , 1995, Biochemistry.

[37]  D. Lane,et al.  Small peptides activate the latent sequence-specific DNA binding function of p53 , 1995, Cell.

[38]  L. Neckers,et al.  Taxol induction of p21WAF1 and p53 requires c-raf-1. , 1995, Cancer research.

[39]  D. Bentley,et al.  The Transcriptional Elongation Inhibitor 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole Inhibits Transcription Factor IIH-associated Protein Kinase (*) , 1995, The Journal of Biological Chemistry.

[40]  P. Hanawalt,et al.  Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Lane,et al.  Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[42]  P. Hanawalt,et al.  Presence of negative torsional tension in the promoter region of the transcriptionally poised dihydrofolate reductase gene in vivo. , 1995, Nucleic acids research.

[43]  K. Kinzler,et al.  p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. , 1995, Genes & development.

[44]  K. Okaichi,et al.  p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines. , 1994, Cancer letters.

[45]  A. Fornace,et al.  The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. , 1994, Cancer research.

[46]  T. Graeber,et al.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.

[47]  P. Hanawalt,et al.  Transcript cleavage by RNA polymerase II arrested by a cyclobutane pyrimidine dimer in the DNA template. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Grant,et al.  Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. , 1994, Cancer research.

[49]  D. Chowdary,et al.  Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway , 1994, Molecular and cellular biology.

[50]  M. Kastan,et al.  DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways , 1994, Molecular and cellular biology.

[51]  L. Liu,et al.  DNA topoisomerases: essential enzymes and lethal targets. , 1994, Annual review of pharmacology and toxicology.

[52]  L. Ferguson,et al.  Topoisomerase II enzymes and mutagenicity , 1994, Environmental and molecular mutagenesis.

[53]  Xin Lu,et al.  Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes? , 1993, Cell.

[54]  C. Job,et al.  Spectrum of DNA--platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases. , 1993, Biochemistry.

[55]  A. Fornace,et al.  Induction of Cellular p53 Activity by DNA-Damaging Agents and Growth Arrest , 1993, Molecular and cellular biology.

[56]  C. N. Coleman,et al.  Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. , 1993, Cancer research.

[57]  C. Purdie,et al.  Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.

[58]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[59]  D. Lane,et al.  Regulation of the specific DNA binding function of p53 , 1992, Cell.

[60]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[61]  P. Friedman,et al.  Wild-type p53 activates transcription in vitro , 1992, Nature.

[62]  A. Levine,et al.  Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. , 1992, Genes & development.

[63]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[64]  M. Yaniv,et al.  Wild-type p53 can down-modulate the activity of various promoters. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[66]  W. Sauerbier,et al.  Structure of transcriptionally active chromatin: Radiological evidence for requirement of torsionally constrained DNA , 1989, Journal of cellular physiology.

[67]  G. Georgiev,et al.  Inhibition of transcription in eukaryotic cells by X-irradiation: relation to the loss of topological constraint in closed DNA loops. , 1988, Nucleic acids research.

[68]  J. Ward,et al.  DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. , 1988, Progress in nucleic acid research and molecular biology.

[69]  A. Eastman.  Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA. , 1986, Biochemistry.

[70]  H. M. Sobell.  Actinomycin and DNA transcription. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[71]  S. Kawamoto,et al.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. , 1984, Biochemistry.

[72]  W. Maltzman,et al.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.

[73]  K. Erixon,et al.  Single-strand breaks in DNA during repair of UV-induced damage in normal human and xeroderma pigmentosum cells as determined by alkaline DNA unwinding and hydroxylapatite chromatography: effects of hydroxyurea, 5-fluorodeoxyuridine and 1-beta-D-arabinofuranosylcytosine on the kinetics of repair. , 1979, Mutation research.

[74]  W. Sauerbier,et al.  Gene and transcription unit mapping by radiation effects. , 1978, Annual review of genetics.

[75]  J. Darnell,et al.  The inhibition of DRB (5,6-dichloro-1-β-d-ribofuranosylbenzimidazole) of hnRNA and mRNA production in HeLa cells , 1976, Cell.

[76]  E. Egyházi.  Initiation inhibition and reinitiation of the synthesis of heterogeneous nuclear RNA in living cells , 1976, Nature.

[77]  M. Kuwano,et al.  Inhibition by alpha-amanitin of messenger RNA formation in cultured fibroblasts: potentiation by amphotericin B. , 1973, Experimental cell research.

[78]  R. Perry,et al.  Inhibition of RNA synthesis by actinomycin D: Characteristic dose‐response of different RNA species , 1970, Journal of cellular physiology.